Want Simpler US Vaccine Recommendations? Bring Better Evidence, Price To CDC, ACIP Head Says

As sponsors complain about difficult-to-implement ACIP recommendations hampering uptake, the government says developers share some of the blame, but adds that it is working to ensure recommendations can be operationalized. 

person getting a vaccine
Uncertainty about a vaccine may lead to shared clinical decision-making, Melinda Wharton said. • Source: Shutterstock

If vaccine manufacturers want smoother uptake of their vaccines in the US, they may want to consider how they study and price them.

Key Takeaways

  • Vaccine manufacturers may need more comprehensive clinical trial data and better price points to get the preferred universal age-based recommendations from the CDC.

Complaints about difficult-to-implement Centers for Disease Control and Prevention vaccine recommendations hindering uptake took center stage at a World Vaccines...

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from US FDA Performance Tracker

More from Regulatory Trackers